Development and evaluation of nanosized aripiprazole-loaded bioflexy films using a biopolymer from  for brain delivery through orosoft palatal mucosal platform

Madhav, N.V. Satheesh; Jaiswal, Vishakha; Ojha, Abhijeet

doi:10.4103/1687-4315.205832

Development and evaluation of nanosized aripiprazole-loaded bioflexy films using a biopolymer from for brain delivery through orosoft palatal mucosal platform

Authors

10.4103/1687-4315.205832

Abstract

Purpose
The National Institute of Mental Health estimated the global cost of mental illness to be $6T by 2030. The purpose of the study was to deliver aripiprazole for brain targeting by suitably designing a bioflexy film for the treatment of different brain disorders.
Materials and methods
Bioflexy films were prepared by solvent casting technique using aripiprazole as a model drug, different concentrations of isolated biopolymer from , and a standard polymer.
Results
All formulations of aripiprazole were flexible, smooth, and transparent in nature, with a weight range from 23.73 to 34.48 mg, pH range from 7.27 to 7.39, and folding endurance of 94–116 times. The content uniformity was in the range of 97.2–98.6.
Conclusion
In-vitro and in-vivo release shows FL2 as the best formulation. On the basis in-vitro and in-vivo drug release, FL2 was found to be best formulation showing mucoadhesivity (36 h), of 2.5 h, of 23.4 h, and having value of 0.9923, best-fit model Higuchi matrix analyzed by BIT-SOFT 1.12. Moreover, it was observed that significant amount of drug reaches to the brain through soft palatal route through neural pathway.

Keywords